Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Central retinal vein occlusion (CRVO)"'
Autor:
Shweta Parakh, Shrey Maheshwari, Shrutanjoy Das, Hans Vaish, Gaurav Luthra, Rupesh Agrawal, Vishali Gupta, Saurabh Luthra
Publikováno v:
Journal of Ophthalmic Inflammation and Infection, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Purpose To report a case of central retinal vein occlusion (CRVO) seven days following the first dose of ChAdOx1 nCoV-19 vaccine and propose a hypothesis for the possible underlying pathogenesis. Observation A 31-year-old male presented with
Externí odkaz:
https://doaj.org/article/8f64306bae994161a0dea3537f07601f
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Retinal vein occlusions (RVOs) are the second most common retinal vascular disease after diabetic retinopathy, and are a significant cause of visual impairment, especially in the elderly population. RVOs result in visual loss due to macular ischemia,
Externí odkaz:
https://doaj.org/article/e8b46a05d57b44698e7caf7fa6b42178
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
MGM Journal of Medical Sciences, Vol 8, Iss 3, Pp 303-307 (2021)
Central retinal vein occlusion (CRVO) is a significant cause of marked or total loss of vision in the middle-aged and elderly population. The patient was a 54-year-old man with a history of uncontrolled diabetes and was given seven intravitreal bevac
Externí odkaz:
https://doaj.org/article/b9784a14ab2f416197c8cf6e151e574d
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
SignificanceCystoid macular edema (CME) is a common complication of retinitis pigmentosa (RP). However, CME in RP with central retinal vein occlusion (CRVO) is rare. Prompt administration of anti-vascular endothelial growth factor (anti-VEGF) medicat
Externí odkaz:
https://doaj.org/article/d8196c6e57f34a64a42114d616ad6c2d
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 8, Iss C, Pp 58-61 (2017)
Purpose: To report the 12-month efficacy and safety outcomes of intravitreal ziv-aflibercept in macular edema secondary to central retinal vein occlusion (CRVO). Methods: Interventional case series documenting 12-month outcomes of intravitreal ziv-af
Externí odkaz:
https://doaj.org/article/5f2e2d5fcbc64cb690144c6cdc71cc45
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 2, Iss C, Pp 26-29 (2016)
Purpose: To report the case of a patient who presented with a vasculitic central retinal vein occlusion (CRVO), which was the result of an undiagnosed systemic inflammatory condition, seronegative rheumatoid arthritis (RA). Observations: The patient
Externí odkaz:
https://doaj.org/article/9b233d83598d4bca8a22f220fb26cd1d
Results of a new method in surgical treatment of central retinal vein occlusion in clinical practice
Publikováno v:
Офтальмохирургия, Vol 0, Iss 3, Pp 28-31 (2015)
Purpose. To improve the effectiveness in treatment of the central retinal vein occlusion (CRVO) using a new method of surgical intervention, including a «massage» of the affected veins with epiretinal Gemaza introduction and retinal photocoagulatio
Externí odkaz:
https://doaj.org/article/fd659476f99d406a97e91d64c54a4162
Autor:
Maurizio Battaglia Parodi, Francesco Bandello, Rosangela Lattanzio, Emanuela Aragona, Alessandro Arrigo, Giovanni Scalia
Publikováno v:
Investigative Ophthalmology & Visual Science
PURPOSE. The purpose of this study was to investigate the effects of the extension of collateral vessels on the outcomes of eyes affected by central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO). METHODS. The study was design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4e24b6b9f591ad1aad6b6e68df32020
http://europepmc.org/articles/PMC8572435
http://europepmc.org/articles/PMC8572435